Total Payments
$14,734
2024 Payments
$1,487
Companies
83
Transactions
885
Medicare Patients
2,447
Medicare Billing
$278,075
Payment Breakdown by Category
Food & Beverage$14,004 (95.0%)
Education$729.73 (5.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,004 | 864 | 95.0% |
| Education | $729.73 | 21 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,471 | 93 | $0 (2024) |
| PFIZER INC. | $1,070 | 83 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $978.74 | 58 | $0 (2024) |
| Janssen Biotech, Inc. | $942.75 | 47 | $0 (2024) |
| Merck Sharp & Dohme LLC | $925.09 | 62 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $607.19 | 50 | $0 (2024) |
| Amgen Inc. | $593.63 | 34 | $0 (2023) |
| Genentech USA, Inc. | $559.76 | 45 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $451.76 | 13 | $0 (2024) |
| Celgene Corporation | $404.72 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,487 | 76 | AstraZeneca Pharmaceuticals LP ($131.00) |
| 2023 | $1,974 | 98 | AstraZeneca Pharmaceuticals LP ($150.46) |
| 2022 | $1,707 | 91 | Novartis Pharmaceuticals Corporation ($179.10) |
| 2021 | $655.99 | 40 | Coherus Biosciences Inc. ($80.75) |
| 2020 | $1,129 | 75 | PFIZER INC. ($136.51) |
| 2019 | $2,207 | 145 | PFIZER INC. ($181.46) |
| 2018 | $2,940 | 187 | Novartis Pharmaceuticals Corporation ($434.36) |
| 2017 | $2,634 | 173 | Novartis Pharmaceuticals Corporation ($432.38) |
All Payment Transactions
885 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 09/12/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: NONE | ||||||
| 09/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Oncology | ||||||
| 09/06/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Education | In-kind items and services | $16.40 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Oncology | ||||||
| 08/12/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Oncology | ||||||
| 08/08/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| 08/05/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Oncology | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Oncology | ||||||
| 07/16/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: HEMATOLOGY | ||||||
| 07/15/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $14.18 | General |
| 07/11/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Oncology | ||||||
| 07/02/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: ONCOLOGY | ||||||
| 06/25/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 492 | 848 | $176,673 | $53,483 |
| 2022 | 6 | 583 | 995 | $171,055 | $63,766 |
| 2021 | 7 | 657 | 1,155 | $210,213 | $82,484 |
| 2020 | 8 | 715 | 1,216 | $203,341 | $78,342 |
Total Patients
2,447
Total Services
4,214
Medicare Billing
$278,075
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 139 | 389 | $91,929 | $28,386 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 270 | 375 | $62,388 | $18,036 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 53 | 53 | $10,981 | $3,293 | 30.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 17 | $7,005 | $2,311 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $4,370 | $1,458 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 162 | 438 | $85,410 | $32,203 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 300 | 435 | $57,420 | $20,943 | 36.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 25 | $10,000 | $3,809 | 38.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 58 | 58 | $9,570 | $3,568 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 23 | 23 | $6,095 | $2,294 | 37.6% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 16 | 16 | $2,560 | $947.84 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 219 | 595 | $115,500 | $45,872 | 39.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 283 | 393 | $51,764 | $19,935 | 38.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 38 | 41 | $16,400 | $6,442 | 39.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 47 | 47 | $12,455 | $4,886 | 39.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 38 | 38 | $6,262 | $2,363 | 37.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 24 | $5,112 | $1,946 | 38.1% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 17 | 17 | $2,720 | $1,041 | 38.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 279 | 681 | $109,100 | $42,394 | 38.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 225 | 283 | $29,572 | $10,753 | 36.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 52 | 58 | $23,200 | $9,349 | 40.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 60 | 60 | $15,900 | $6,014 | 37.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 30 | 65 | $13,845 | $5,416 | 39.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 40 | 40 | $6,280 | $2,271 | 36.2% |
| 38222 | Bone marrow biopsy and aspiration | Facility | 2020 | 17 | 17 | $2,720 | $1,080 | 39.7% |
About Dr. Gary Engstrom, MD
Dr. Gary Engstrom, MD is a Internal Medicine healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336149731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Engstrom, MD has received a total of $14,734 in payments from pharmaceutical and medical device companies, with $1,487 received in 2024. These payments were reported across 885 transactions from 83 companies. The most common payment nature is "Food and Beverage" ($14,004).
As a Medicare-enrolled provider, Engstrom has provided services to 2,447 Medicare beneficiaries, totaling 4,214 services with total Medicare billing of $278,075. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology, Hematology & Oncology
- Location Texarkana, TX
- Active Since 07/28/2005
- Last Updated 04/24/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1336149731
Products in Payments
- KEYTRUDA (Biological) $706.63
- IMBRUVICA (Drug) $576.46
- KISQALI (Drug) $385.33
- OPDIVO (Biological) $374.69
- BOSULIF (Drug) $297.97
- PROMACTA (Drug) $284.05
- GILOTRIF (Drug) $238.90
- XALKORI (Drug) $218.77
- XTANDI (Drug) $210.86
- DARZALEX (Biological) $209.98
- JAKAFI (Drug) $207.72
- IMFINZI (Drug) $203.94
- VELCADE (Drug) $203.35
- Lenvima (Drug) $197.25
- MEKINIST (Drug) $187.88
- PADCEV (Biological) $178.43
- LYNPARZA (Drug) $170.27
- Udenyca (Biological) $169.92
- IBRANCE (Drug) $169.52
- JEVTANA (Drug) $166.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Texarkana
Dr. Sunil Patel, M.d, M.D
Internal Medicine — Payments: $17,072
Internal Medicine $17,072
Dr. Gregory White, Md, MD
Internal Medicine — Payments: $12,091
Internal Medicine $12,091
Rajeev Patel, M.d, M.D
Internal Medicine — Payments: $8,180
Internal Medicine $8,180
Poongodhai Ramachandran, Md, MD
Internal Medicine — Payments: $5,002
Internal Medicine $5,002
Dr. Pui-Sum Wong, M.d, M.D
Internal Medicine — Payments: $4,811
Internal Medicine $4,811
John Griffin, Md, MD
Internal Medicine — Payments: $4,034
Internal Medicine $4,034